Dr. Daniel Felsky is an Independent Scientist and Head of Whole Person Modeling in the Krembil Centre for Neuroinformatics at CAMH.
Dr. Felsky completed his PhD in neuroimaging and genetics of Alzheimer’s disease at CAMH in 2015. Following this, Dr. Felsky completed postdoctoral fellowships at the Anne Romney Center for Neurologic Diseases at Brigham and Women’s Hospital, Harvard Medical School, in Boston, and the Centre for Translational and Computational Neuroimmunology at Columbia University Medical Centre in New York. As a postdoctoral fellow, Dr. Felsky studied the genetic links between central and peripheral immune diseases and the morphology of the brain’s resident immune cells, microglia. While in Boston and New York, Dr. Felsky collaborated closely with investigators at Rush University Medical Centre in Chicago, publishing the first genome-wide study of microglial activation in humans.
Areas of Research
Dr. Felsky has experience across several areas including structural brain imaging, human genomics and transcriptomics, biostatistics, psychiatric epidemiology, and study design, and has published work on the genetic causes of Alzheimer’s disease, brain structural deficits in schizophrenia and bipolar disorder, as well as the pharmacogenetics of antipsychotic treatment response. In addition to his research, Dr. Felsky is a passionate teacher, and has led curriculum and teaching efforts as a Fellow for the Harvard Global Initiative for Neuropsychiatric Genetics Education in Research, co-sponsored by the Stanley Centre for Psychiatric Research at the Broad Institute of MIT and Harvard.
Publications Link: https://scholar.google.ca/citations?user=L75YFRkAAAAJ&hl=en